Related Experiment Videos
Long-term effects of metaproterenol in asthmatic children
Abstract:
Oral metaproterenol was administered daily for 3 months to asthmatic children. The study was designed to determine whether chronic tolerance developed to this drug. Initial and final crossovers on the first 2 and the last 2 days of the investigation to a test dose of metaproterenol and placebo failed to show tolerance as indicated by improvement in lung volumes and dynamic mechanics of breathing after metaproterenol. Forced expiratory volume in 1 sec was the test most consistent in demonstrating bronchodilation; the action of metaproterenol. Forced expiratory volume in 1 sec was the test most consistent in demonstrating bronchodilation; the action of metaproterenol appeared to last at least 5 hours as measured by this test. T of distribution of ventilation, e.g., single- and multiple-breath nitrogen washout tests, were not consistently altered by metaproterenol. These tests did not appear to be sufficiently sensitive to detect improvement even when airway resistance decreased and forced expiratory volume in 1 sec increased toward the normal range.
Insights
Asthmatic children did not develop tolerance to oral metaproterenol after 3 months of daily use. Lung function tests consistently showed bronchodilation, indicating sustained effectiveness of metaproterenol.
Area of Science:
- Pediatric Pulmonology
- Pharmacology
- Respiratory Medicine
Background:
- Asthma management in children often involves bronchodilators.
- Chronic administration of beta-agonists can potentially lead to tolerance.
- Metaproterenol is a bronchodilator used for asthma treatment.
Purpose of the Study:
- To investigate the development of chronic tolerance to oral metaproterenol in children with asthma.
- To assess the sustained efficacy of metaproterenol over a 3-month treatment period.
Main Methods:
- A 3-month daily oral administration of metaproterenol in pediatric asthma patients.
- Cross-over design with test doses of metaproterenol and placebo at the beginning and end of the study.
- Evaluation of lung volumes and dynamic respiratory mechanics, including Forced Expiratory Volume in 1 second (FEV1).
- Assessment using single- and multiple-breath nitrogen washout tests to evaluate ventilation distribution.
Main Results:
- No significant evidence of chronic tolerance to metaproterenol was observed.
- Forced Expiratory Volume in 1 second (FEV1) consistently demonstrated bronchodilation.
- The bronchodilatory effect of metaproterenol, measured by FEV1, appeared to persist for at least 5 hours.
- Ventilation distribution tests (nitrogen washout) were not consistently altered and showed limited sensitivity.
Conclusions:
- Chronic daily oral metaproterenol administration did not lead to tolerance in asthmatic children.
- Metaproterenol demonstrated sustained bronchodilatory effects, particularly evident in FEV1 measurements.
- Standard lung function tests like FEV1 are reliable indicators of metaproterenol's efficacy, while ventilation distribution tests may be less sensitive in this context.